van Aerde, K.J., Kalverdijk, L.J., Reimer, A.G., Widdershoven, J.A. (2008). QT interval prolongation and psychotropic drugs in children and adolescents: proposed quideline. Nederlands Tijdschrift voor Geneeskunde; 152(32): 1765-70.

Biederman, J., Spencer, T.J., Monuteaux, M.C. et al. (2010). A naturalistic 10-year prospective study of height and weight in children with attention-deficit hyperactivity disorder grown up: sex and treatment effects.  Journal of Pediatrics. 157(4):635-40.

Cahn, W., Ramlal, D., Bruggeman, R., de Haan, L., Scheepers, F.E., van Soest, M.M., Assies, J., Slooff, C.J. (2008). Preventie en behandeling van somatische complicaties bij antipsychoticagebruik. Tijdschrift voor Psychiatrie; 50(9): 579-591.

Correl, C.U. (2007). Weight Gain and Metabolic Effects of Mood Stabilizers and Antipsychotics in Pediatric Bipolar Disorder: A Systematic Review and Pooled Analysis of Short-Term Trials. JAACAP; 46: 687-700.

Devinsky, O., Honigfeld, G., Patin, J.(1991). Clozapine-related seizures. Neurology; 41(3):369-371.

Efron, D., Jarman, F., Barker, M. (1997a). Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial. Pediatrics; 100(6): E6.

Efron, D., Jarman, F., Barker, M. (1997b) Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics; 100(4): 662-666.

Faraone, S.V., Biederman, J., Morley, C.P., Spencer, T.J. (2008). Effect of stimulants on height and weight: a review of the literature. JAACAP; 47(9): 994-1009.

Faraone, S., Buitelaar, J. (2010) Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. European Child & Adolescent Psychiatr; 19(4):353-64.

Findling, R.L., Robb, A., Nyilas, M., Forbes, R.A., Jin, N., Ivanova, S., Marcus, R., McQuade, R.D., Iwamoto, T., Carson, W.H. (2008). A multiple-center, randomized, double blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia. American Journal of Psychiatry; 165(11): 1432-41.

Friedman, R.A., Leon, A.C. (2007). Expanding the black box – depression, anti-depressants and the risk of suicide. The New England Journal of Medicine; 356(23): 2343-6.

Gilbert, D.L., Batterson, J.R., Sethuraman, G., Sallee, F.R. (2004). Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial. JAACAP; 43(2): 206-214.

Greenhill, L., Kollins, S., Abikoff, H. et al. (2006). Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. JAACAP; 45: 1284-1293.

Gründer, G., Carlsson, A., & Wong, D.F. (2003). Mechanism of New Antipsychotic Medications: Occupancy Is Not Just Antagonism. Archives of General Psychiatry, 60(10), 974 -977.

Gutgesell, H., Atkins, D., Barst, R., Buck, M., Franklin, W., Humes, R. et al. (1999). Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: A statement for healthcare professionals from the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation; 99(7): 979-982.

Malone, R.P., Maislin, G., Choudhury, M.S., Gifford, C., Delaney, M.A. (2002). Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness. JAACAP; 41(2): 140-147

Mannuzza, S., Klein, R., Truong, N. et al. (2008). Age of Methylphenidate Treatment Initiation in Children With ADHD and Later Substance Abuse: Prospective Follow-Up Into Adulthood. American Journal of Psychiatry; 165:604–609.

Olfson, M., Huang, C., Gerhardt, T. et.al. (2012). Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder. JAACAP; 51(2) 147-56.

Vorstman, J., Lahuis, B., Buitelaar, J.K. (2001). SSRIs associated with behavioral activation and suicidal ideation. JAACAP; 40(12): 1364-1365

Ruth, U., Mayer-Rosa, J., Schlamp, D., Freisleder, F.J. (2000). Tourette´s syndrome and antidepressant therapy: exacerbation of nervous tics with paroxetine. Zeitschrift fur Kinder-undJugendpsychiatrie und Psychotherapie; 28(2): 105-108

Richardson, G., Wang-Weigand, S. (2009) Effects of long-term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomnia. Human Psychopharmacology; 24(2): 103-11.

Schubiner, H., Saules, K.K., Arfken, C.L., Johanson, C.E., Schuster, C.R., Lockhart, N. et al. (2002). Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Experimental and Clinical Psychopharmacology; 10(3): 286-294

Westermann, G.M.A., McGregor-Schuerman, M.M.I.L., Langenaken, M.J.M.C. et al. (2013) Antipsychotica, overgewicht en metabole afwijkingen bij kinderen en jeugdigen. Psyfar;8(2): 10-18.

Wilens, T.E., Biederman, J., Baldessarini, R.J., Geller, B., Schleifer, D., Spencer, T.J. et al. (1996). Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. JAACAP; 35(11): 1491-1501.